Percutaneous bone biopsy in the diagnosis of renal osteodystrophy

Seminars in Nephrology

Volumn 22, Issue 3, 2002, Pages 268-275

  Ho, Louisa T ^a   Sprague, Stuart M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; PARATHYROID HORMONE;

BIOPSY TECHNIQUE; BONE BIOPSY; COMPLICATION; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; EQUIPMENT; HUMAN; HUMAN TISSUE; OSSIFICATION; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW;

EID: 0036092986     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2002.31714     Document Type: Review

References (38)

1. The role of bone biopsy in the management of patients with renal osteodystrophy
2. Renal osteodystrophy
3. 3 and radiology in end-stage renal disease
4. The spectrum of bone disease in end-stage renal failure. An evolving disorder
5. Renal osteodystrophy in dialysis patients: Diagnosis and treatment
6. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study
7. Disappearance of aluminum bone disease in a long term asymptomatic dialysis population restricting aluminum hydroxide intake: Emergence of an idiopathic adynamic bone disease not related to aluminum
8. Relative hypoparathyroidism and adynamic bone disease
9. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease
10. Adynamic bone disease: Pathogenesis, diagnosis and clinical relevance
11. Aplastic osteodystrophy without aluminum: The role of suppressed parathyroid function
12. Stainable aluminum and not aluminum content reflect histologic changes in bone of dialyzed patients
13. Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH
14. Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients
15. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis
16. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia
17. Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in haemodialysis patients
18. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum
19. Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology
20. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients
21. Biochemical markers of bone turnover: Methodology and clinical use in osteoporosis
22. Circulating biochemical markers of bone remodeling in uremic patients
23. Markers of bone remodeling in metabolic bone disease
24. Serum bone G1a-protein in renal osteodystrophy: Comparison with bone histomorphometry
25. Concurrent assays of circulating bone G1a protein and bone alkaline phosphatase: Effect of sex, age and metabolic bone disease
26. Serum type I procollagen peptide: A non-invasive index of bone formation in patients on hemodialysis?
27. Procollagen type I C-terminal extension peptide in predialysis chronic renal failure
28. Procollagen type I C-terminal extension peptide, PTH, and 1,25 vitamin D in chronic renal failure
29. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: Potential use to assess bone resorption
30. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients
31. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy
32. Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone disease
33. Serum pyridinolines as specific markers of bone resorption in hemodialyzed patients
34. Percutaneous biopsy of the iliac crest
35. Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone diseases
36. Outpatient percutaneous biopsy of the iliac crest: Methods, morbidity and patient acceptance
37. Complications of bone biopsies
38. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee